Torrent Pharmaceuticals Limited
TORNTPHARM
Rank in Stocks
#1200
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Share Price
$50.31
Last synced: 2026-10-19
Market Cap
$19.14B
Change (1 day)
-0.14%
Change (1 year)
23.32%
Country
IN
Trade Torrent Pharmaceuticals Limited (TORNTPHARM)
Category
Healthcare
Revenue for Torrent Pharmaceuticals Limited (TORNTPHARM)
Revenue in Jun 2026 TTM: $1.72B
According to Torrent Pharmaceuticals Limited latest financial reports the company's current revenue (TTM) is $1.72B. In 2024 the company made a revenue of $1.29B an increase over the revenue in the year 2023 that was $1.17B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Torrent Pharmaceuticals Limited from 2005 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.72B | 27.98% |
| 2025 | $1.35B | 4.66% |
| 2024 | $1.29B | 9.91% |
| 2023 | $1.17B | 4.44% |
| 2022 | $1.12B | 2.50% |
| 2021 | $1.09B | 3.76% |
| 2020 | $1.05B | -4.62% |
| 2019 | $1.10B | 20.92% |
| 2018 | $913.81M | 1.90% |
| 2017 | $896.80M | -10.88% |
| 2016 | $1.01B | 34.94% |
| 2015 | $745.76M | -3.94% |
| 2014 | $776.35M | 31.37% |
| 2013 | $590.99M | 15.51% |
| 2012 | $511.64M | 7.45% |
| 2011 | $476.15M | 11.61% |
| 2010 | $426.62M | 32.82% |
| 2009 | $321.20M | -5.13% |
| 2008 | $338.57M | 13.00% |
| 2007 | $299.62M | 37.98% |
| 2006 | $217.15M | 73.11% |
| 2005 | $125.44M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 283.67% |
IN
|
